search
stem cells
Trends
- 1
Researchers report that artificial intelligence can identify signs of aging in blood stem cells by analyzing images of cell nuclei alone, without other biological markers. The finding suggests nuclear appearance carries measurable information about cellular aging. If validated, the approach could offer a simpler way to study blood stem cell aging and age-related declines in the immune and blood systems.
- 2EU approves first drug for cerebral adrenoleukodystrophy▼European Commission grants marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative disease
The European Commission has granted marketing authorization for NEZGLYAL (leriglitazone), making it the first pharmacological treatment approved for cerebral adrenoleukodystrophy, a rare and rapidly progressive neurodegenerative disease that primarily affects young boys. Until now, care options for cALD were limited mainly to stem cell transplantation in eligible patients. The approval is being highlighted as a significant milestone for families affected by the rare disease and for rare-disease drug development in Europe.
- 3
Researchers report that artificial intelligence can distinguish aged stem cells from young ones, potentially by analysing imaging data, according to an announcement carried by EurekAlert. The finding could improve understanding of how ageing affects stem cell function and support research into regenerative medicine and age-related disease.
- 4EU approves NEZGLYAL, first drug for childhood cerebral ALD▼European Commission grants marketing authorisation for NEZGLYAL, first pharmacological treatment for cALD
The European Commission has granted marketing authorisation for NEZGLYAL, the first pharmacological treatment for childhood cerebral adrenoleukodystrophy (cALD), a rare and severe genetic brain disorder. Until now, treatment options were largely limited to stem cell transplantation and supportive care. The approval offers a new therapy option for patients across the EU and is being noted in rare disease and biotech circles.
- 5Scientists explore growing replacement teeth to regrow lost ones▼Lost a tooth? Science may one day grow it back
Research into tooth regeneration is drawing attention, with reports suggesting science may one day allow people to regrow lost teeth instead of relying on implants or dentures. The work builds on studies of stem cells and the biological mechanisms that form teeth during development, raising hopes for future clinical treatments.
- 6Patient Cell Reprogramming Points to Reversible Cause of Childhood Hip Disease●Reprogramming Patient Cells Reveals a Reversible Signalling Flaw Behind a Childhood Hip Disease
Researchers reprogrammed cells from young patients to study a childhood hip disease, and report identifying a signalling defect that appears reversible. The work suggests the underlying cellular error driving the condition may be correctable rather than permanent, raising the prospect of future therapeutic approaches. Details of the study, including the specific disease and signalling pathway involved, have not been broadly reported yet.